Beta-sheet Structures
Beta-sheet Structures - Related Videos
05:58
Light-Sheet Imaging to Reveal Cardiac Structure in Rodent Hearts
0 Views •
Cited by 9 •
2024
The protocol utilizes advanced light-sheet microscopy along with adapted tissue clearing methods to investigate intricate cardiac structures in rodent hearts, holding great potential for the understanding of cardiac morphogenesis and remodeling.
01:25
Beta
0 Views •
2024
Beta is a crucial metric in finance used to assess an investment's risk and expected return relative to the overall market. It is calculated as the slope of the line in a scatterplot that compares the returns of an individual stock to the returns of the market benchmark, typically represented by a broad market index. Beta quantifies how much a stock's price moves in response to market movements, providing insight into its volatility and systematic risk. A beta of one indicates that the stock's...
09:50
In situ Quantification of Pancreatic Beta-cell Mass in Mice
0 Views •
Cited by 6 •
2010
The following protocol outlines the process of pancreatic dissection for virtual slice imaging, and the subsequent quantification of all GFP-tagged beta-cells in the entire pancreas.
01:23
Balance Sheet
0 Views •
2024
A balance sheet is a key component of financial statement analysis. It provides a snapshot of a company's financial position at a given time by listing its assets, liabilities, and shareholders' equity. It includes both current and long-lived assets and current and long-term liabilities. Assets reflect what the company owns, such as cash, inventory, and real estate, whereas liabilities represent what the company owes, including debts like loans and accounts payable. Balance sheet analysis is...
03:14
Imaging Amyloid-Beta Plaques in Brain Tissue Sections by Immunolabeling and Curcumin Staining
0 Views •
2025
Source: Maiti, P. et. al.,. Labeling and Imaging of Amyloid Plaques in Brain Tissue Using the Natural Polyphenol Curcumin. J. Vis. Exp. (2019)This video demonstrates the imaging procedure of amyloid-beta plaques in brain tissue sections using immunolabeling and curcumin staining. Immunolabeling provides specificity for amyloid-beta, while curcumin selectively binds β-sheet-rich fibrils, enhancing visualization. The co-localization of red and green fluorescence confirms the presence of plaques.
FAQs
The orientation of neighboring strands changes how the sheet is organized, because strands may run in parallel or antiparallel directions while remaining connected through backbone hydrogen bonds. This distinction gives researchers a structural feature to examine when relating protein folding patterns to molecular shape and stability, without treating all beta-sheet arrangements as identical.
Side chains project alternately above and below the sheet, creating a repeating arrangement around the hydrogen-bonded backbone. That organization contributes to the overall shape and stability of the protein structure. Examining side-chain positioning therefore helps researchers connect secondary-structure patterns with the physical characteristics of folded proteins and with changes associated with misfolding.
In misfolded proteins, increased beta-sheet content is associated with a greater tendency to organize into aggregated structures. For amyloid-beta and tau, this enrichment promotes formation of fibrils and plaques, which are linked with neurodegenerative disease. Studying the structural shift helps researchers investigate how abnormal protein folding may contribute to disease mechanisms.
Researchers examine beta-sheet enrichment in amyloid-beta and tau to connect protein misfolding with the formation of fibrils and plaques. This structural perspective supports investigation of how abnormal protein conformations relate to neurodegenerative disease. It also provides a framework for comparing normal protein stability with disease-associated aggregation and for identifying structural changes relevant to pathogenesis.
Beta-sheet enrichment provides a structural characteristic associated with misfolded amyloid-beta and tau. Because these proteins form fibrils and plaques linked with neurodegenerative disease, their structural features can guide biomarker research. The goal is to use information about protein misfolding and aggregation to support investigation of disease-associated changes and their potential measurement.
Understanding how beta-sheet enrichment relates to fibril and plaque formation can help researchers focus on aggregation as a therapeutic target. In neuroscience, this approach connects protein structure with disease-associated accumulation of amyloid-beta and tau. Structural knowledge therefore supports exploration of interventions intended to address abnormal aggregation rather than examining disease processes without a protein-folding framework.